Introduction
============

microRNAs (miRNAs) are a class of \~22 nucleotide non-coding RNAs that regulate gene expression at the posttranscriptional level. Recent studies have revealed that miRNAs play important roles in cardiovascular development and diseases [@B1]-[@B5]. In particular, the muscle-specific, cardiac-enriched miRNA *miR-1* has been shown to control cardiac excitability by regulating expression of ion channel genes [@B5]-[@B7]. This property of *miR-1* confers it the ability to modulate cardiac electrical activities and the associated arrhythmogenic potential. For example, our previous study demonstrated that *miR-1* expression was significantly up-regulated in post-myocardial ischemia (MI) hearts from both patients and rats and this upregulation promotes ischemic arrhythmias by slowing cardiac conduction via repressing *KCNJ2* and *GJA1* genes encoding inward rectifier K^+^ channel subunit and gap junctional channel connexin 43 (Cx43), respectively [@B6]. A subsequent study showed that forced expression of *miR-1* by adenovirus promotes arrhythmogenic disturbances in Ca^2+^ cycling of cardiomyocytes by enhancing the functional activity of RyR2 channels [@B7]. Noteworthy is that in these studies, knockdown of *miR-1* is able to prevent or reverse the arrhythmogenic actions, indicating *miR-1* as a target for anti-arrhythmic therapy. This notion has indeed been evidenced by our recent studies showing the antiarrhythmic efficacy of beta-adrenergic receptor blockers and tanshinone IIA with downregulation of *miR-1* as a mechanism [@B8], [@B9].

However, in all these above studies upregulation of *miR-1* was transient. Whether long-term overexpression of *miR-1* affects cardiac excitability and arrhythmogenesis remained unknown. To resolve this issue, we generated a Tg mouse line with cardiac-specific overexpression of miR-1 and investigated the impact of miR-1 overexpression on cardiac electrical activities and the targeting mechanisms.

Materials and Methods
=====================

Generation of miR-1 Tg mice
---------------------------

A fragment (264 bp) containing the precursor miR-1-2 (pre-miR-1-2) sequence was amplified by polymerase chain reaction (PCR) (accession No. NT_039674). The fragment was then subcloned into the SalI and HindIII sites of the Bluescript vector (Promega, Madison, WI) carrying the cardiac-specific α-myosin heavy chain (α-MHC) promoter and human growth hormone poly(A)^+^signal. The plasmid was digested at the SpeI site to release the premiR-1 sequence flanked by 5\'end α-MHC promoter and 3\'end poly (A). The fragment was separated on an agarose gel and purified by QIAEX II gel extraction kit (Qiagen No. C04539; Valencia, CA). The DNA sample was prepared at a concentration of 2 ng/μL ready for injection. A Tg mouse line carrying a mismatched premiR-1 sequence was also generated for negative control experiments. Sexually immature female mice (4 to 5 weeks of age) were superovulated by consecutive PMS and HCG hormone injections to obtain sufficient quantity of eggs (\>250) for injection. These female mice were mated with vasectomized males immediately after the HCG injection. Eggs were harvested the next day from the ampulla of the oviduct of the mated females and treated with hyaluronidase to remove nurse cells. Fertilized eggs were then stored in M16 media (37°C, 5% CO~2~) until injection. Each egg was individually microinjected with the DNA fragment, and the eggs that did not survive injection were removed. Pseudopregnant female mice were prepared by mating with the vasectomized males. On the day of microinjection, the pseudopregnant females were anesthetized with 0.5% pentobarbital (80 mg/kg intraperitoneal injection). Anesthesia was monitored by reaction to foot pinching at 15 min intervals and respiration monitoring and maintained by supplementary infusions of pentobarbital. The injected eggs were then implanted in a group of 10 to 15 bilaterally into the oviduct of these animals. The animals were allowed to recover from anesthesia on a warming plate and then brought back to the animal room. They were kept under sterile conditions throughout their pregnancy. The genomic DNA was prepared from tail tissue of the Tg mice and subjected to PCR verification for the presence of miR-1 transgene. The forward primer was designed to recognize α-MHC (position 5250 to 5268): 5\'-CCTTACCCCACATAGACCT-3\'and the reverse primer was for miR-1 (position 58 to 39): 5\'-CTGTAGATACTTTCTCCCT-3\'. The PCR profiling was composed of an initial denaturing step at 94 °C for 2 min and 35 cycles of 94 °C for 20 sec, 60 °C for 7 sec, and 72 °C for 20 sec, followed by a final extension step at 72 °C for 5 min. All animal procedures were approved by the Ethical Committee for Animal Experiments, Harbin Medical University, and confirmed with the *Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education* by the New York Academy of Sciences, Ad Hoc Animal Research Committee.

Electrocardiograms and assessment of arrhythmias
------------------------------------------------

Mice were anesthetized with pentobarbital (80 mg/kg, intraperitoneal injection). Cardiac arrhythmia in *miR-1* Tg mice was monitored using a standard lead II ECG for a continuous period of 2 h under anesthesia. Incidence of arrhythmias was evaluated.

Isolation of mouse ventricular myocytes
---------------------------------------

The heart was quickly excised from mice under deep anesthesia with pentobarbital (120 mg/kg, intraperitoneal injection) and was retrogradely perfused by using a Langendorff perfusion system for 5 min at 37 °C, at a perfusion rate of 7 mL/min with Ca^2+^-containing Tyrode\'s solution [@B6], [@B9]. The perfusate was then switched to a Ca^2+^-free Tyrode\'s solution for 5 min, followed by perfusion with the same solution to which collagenase (type II, 100-150 kU/L, Worthington, Lakewood, NJ) and 1% bovine serum albumin (Sigma-Aldrich, St. Louis, MO) had been added. The left ventricular tissue was then excised from the softened hearts, minced, and placed in a KB medium at 4 °C for about 1 h before electrophysiological experiments. This procedure typically yielded 50% rod-shaped Ca^2+^-tolerant cardiomyocytes. Only single rod-shaped cells with clear cross-striation and without spontaneous contraction were used for experiments.

Whole-cell patch-clamp recording
--------------------------------

The whole-cell patch-clamp techniques were used to record ionic currents in the voltage-clamp mode using an Axopatch 200B amplifier controlled by a personal computer using a Digidata1200 acquisition board driven by pCLAMP software (Version 9.02, Axon Instruments) [@B6], [@B9]. Borosilicate glass electrodes had tip resistances of 2\~4 MΩ when filled with the internal pipette solution. Data were high-pass filtered 10 kHz. Calcium and potassium currents were recorded at room temperature (22\~23 °C). The measured currents were normalized by whole-cell capacitance. Series resistance compensation was typically 50\~80%. Data were analyzed with Graphpad Prism 5.0 software.

The KB solution contained (in mM) glutamic acid 70, taurine 15, KCl 30, KH~2~PO~4~ 10, MgCl~2~ 0.5, EGTA 0.5, HEPES 10, and glucose 10 at pH 7.4 adjusted by KOH. The standard Tyrode\'s solution contained (in mM) NaCl 126, KCl 5.4, MgCl~2~ 1, CaCl~2~ 1.8, NaH~2~PO~4~0.33, glucose 10, and HEPES 10 at pH 7.4 adjusted by NaOH. This solution was used as an extracellular solution for potassium currents studies. The pipette solution for potassium currents recordings contained (in mM) KCl 20, K-aspartate 110, MgCl~2~ 1.0, HEPES 5, EGTA 10, Na~2~ATP 5 at pH 7.2 adjusted by KOH. For K^+^ currents recordings, *I*~Na~ was inactivated by using a holding potential (HP) of -40 mV. Calcium currents were blocked by the use of CdCl~2~ (0.2 mM, Sigma) in the extracellular solution. The extracellular solution for L-type Ca^2+^ current (*I*~Ca,L~) recording contained (in mM) Tris-Cl 136, CsCl 5.4, CaCl~2~ 2, MgCl~2~^.^6H~2~O 1, HEPES 10, and glucose 5, pH 7.4 with Tris-OH. The internal solution for *I*~Ca,L~ recording contained (in mM) CsCl 20, MgCl~2~^.^6H~2~O 1, MgATP 5, EGTA 10, and CsCl^.^H~2~O 110, aspartate 110, pH adjusted to 7.2 with CsOH.

Determination of miR-1 levels in Tg mice
----------------------------------------

Total RNA samples were extracted using Trizol from mice left ventricular tissues. miR-1 level was quantified by the TaqMan® MicroRNA Reverse Transcription Kit (Cat.\#4366596, Applied Biosystems, Carlsbad, CA) and the TaqMan® MicroRNA Assay (target sequences: UGGAAUGUAAAGAAGUAUGUAU, Cat.\#002222, Applied Biosystems, Carlsbad, CA) [@B6], [@B8], [@B9]. We used U6 (Cat.\#001973, Applied Biosystems, Carlsbad, CA) as an internal control. qRT-PCR was performed on 7500 FAST Real-Time PCR System (Applied Biosystems, Carlsbad, CA) for 40 cycles.

Western blot
------------

The membrane protein samples were extracted from mouse ventricles for immunoblotting analysis of Cx43. Mice left ventricles were quickly rinsed in a standard Tyrode\'s solution, snap frozen in liquid nitrogen and stored at -80 °C for western blot analysis. The protein content was determined with BCA Protein Assay Kit (Bio-Rad, Mississauga, ON, Canada). Equal amounts of protein (60 μg) were loaded on a 10% SDS-PAGE gel. The lysates were resolved by electrophoresis (70 V for 30 min and 100 V for 1.5 h) and transferred onto nitrocellulose membranes. After blocking in 5% nonfat milk for 2 h at room temperature the membranes were treated with anti-Cx43 or anti-Kir2.1 antibody (1:200). Next day, the membrane was washed in PBS for three times (15 min/each) and incubated for 1.5 h with the fluorescence-conjugated anti-rabbit IgG (1:4000) in the blocking buffer. GAPDH was used as an internal control for equal input of protein samples. All primary and secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Western blot bands were quantified using Odyssey v1.2 software by measuring the band intensity (Area × OD) for each group and normalized by GAPDH. The final results are expressed as fold changes by normalizing the data to the control values.

Measurement of intracellular Ca^2+^ concentration (\[Ca^2+^\]~i~)
-----------------------------------------------------------------

Intracellular Ca^2+^ concentration (\[Ca^2+^\]~i~) was assessed using fluo-3/AM (5 µM/L, Life Technologies, Grand Island, NY) [@B10]. Pluronic F-127 (Invitrogen, Eugene, OR), a mild detergent, is used as a dispersing agent to facilitate the loading and the final concentration in the loading medium is 0.04%. Fluorescent changes of fluo-3/AM-loaded cells were detected using laser scanning confocal microscope (Olympus FV-300) with 488 nm for excitation from an argon ion laser and 530 nm for emission. Resting \[Ca^2+^\]~i~ was investigated in fluo-3/AM-loaded cells in standard Tyrode\'s solution at 23-24 °C. To measure peak \[Ca^2+^\]~i~, 60 mmol/L KCl was added between 1^st^ and 2^nd^ scan, and changes of \[Ca^2+^\]~i~ in response to KCl stimulation was recorded. The fluorescent intensities before (FI~0~) and after (FI) KCl administration were measured. Qualitative changes in \[Ca^2+^\]~i~ were inferred from the ratio of FI/FI~0~.

In vivo transfer of locked nucleic acid (LNA)-modified antimiR-1 oligomers
--------------------------------------------------------------------------

The LNA-modified oligonucleotides were synthesized as unconjugated LNA/DNA mixers with a complete phosphorothioate backbone. Mice were caudally administered 5 mg/kg LNA-antimiR-1 intravenous injection daily on day 1, 3 and 5. A vehicle control was administered with the same volume of phosphate buffered saline (PBS). The experiments were performed three days after LNA-antimiR-1 injection.

Statistics
----------

Data are expressed as means ± SEM. Statistical analysis was performed using the Student\'s *t*-test. Differences were considered to be significant when *p*\<0.05.

Results
=======

*miR-1* causes atrioventricular block in mice
---------------------------------------------

We established a *miR-1* Tg mouse line that produces stable overexpression of *miR-1* specifically in the myocardium as indicated by the significantly increased *miR-1* level in Tg relative to WT mice (Fig. [1](#F1){ref-type="fig"}A & [1](#F1){ref-type="fig"}B; *p*\<0.05). We also confirmed using western blot analysis that Cx43 and Kir2.1 protein levels were significantly downregulated in myocardium from Tg mice compared with that in WT mice (Fig. [1](#F1){ref-type="fig"}C; *p*\<0.05, n=6), consistent with our previous finding that *miR-1* represses Cx43 and Kir2.1 [@B6], [@B8], [@B9].

Most notably, the *miR-1* Tg mice developed frequent AVB of varying degrees with prolongation of PR interval (first degree AVB), dropped ventricular beats (second degree of AVB), and even dissociation between P waves and QRS complexes (third degree AVB). Representative ECG recordings showing typical characteristics of AVB from *miR-1* Tg are presented in Fig. [1](#F1){ref-type="fig"}D. While the incidence of AVB was as high as 90%, it was absent in WT mice (Fig. [1](#F1){ref-type="fig"}D & [1](#F1){ref-type="fig"}E).

Knockdown of *miR-1*attenuates atrioventricular block in mice
-------------------------------------------------------------

To see if the AVB was indeed caused by *miR-1* overexpression, we used locked nucleic acid-modified anti-*miR-1* antisense (LNA-anti-*miR-1*) to normalize *miR-1* level by knocking down its expression [@B11] and investigated the effects on AVB in Tg mice. LNA-anti-*miR-1*was injected via caudal vein to *miR-1* Tg mice. ECG recordings showed that the LNA-anti-*miR-1* significantly decreased the propensity of AVB in *miR-1* Tg mice (Fig. [1](#F1){ref-type="fig"}F). The efficacy of *miR-1* knockdown by the LNA-anti-*miR-1* was verified by the drastic decrease in *miR-1* level in the myocardium of *miR-1* Tg mice (Fig. [1](#F1){ref-type="fig"}G).

*I*~Ca,L~ and *I*~K1~ current densities were decreased in *miR-1*Tg mice
------------------------------------------------------------------------

To shed light on the possible mechanisms underlying *miR-1*-induced AVB, we evaluated the changes of L-type Ca^2+^ current (*I*~Ca,L~) that is known to be the major governor of AV conduction [@B12]-[@B16]. We found that the current density of *I*~Ca,L~ was remarkably decreased in *miR-1* Tg mice. The decrease was voltage-dependent at potentials ranging from -30 mV to +30 mV (Fig. [2](#F2){ref-type="fig"}A; *p*\<0.05, n=12 cells from 8 mice). Additionally, the current density of inward rectifier K^+^ current (*I*~K1~), the main determinant of cardiac membrane potential and thereby conduction, was also found smaller in *miR-1* Tg mice compared with that in WT (Fig. [2](#F2){ref-type="fig"}B; *p*\<0.05, n=11 cells from 8 mice).

*miR-1* induces aberrant intracellular Ca^2+^ handling
------------------------------------------------------

Changes of resting \[Ca^2+^\]~i~ and peak \[Ca^2+^\]~i~ upon stimulation with KCl (60 mM/L) to evoke Ca^2+^ entry were investigated in fluo-3/AM loaded cardiac myocytes (Fig. [3](#F3){ref-type="fig"}A). The fluorescence measurements revealed that the resting \[Ca^2+^\]~i~ was remarkably higher in cardiomyocytes from *miR-1* Tg mice than that in WT mice (Fig. [3](#F3){ref-type="fig"}B; *p*\<0.01). However, the peak \[Ca^2+^\]~i~ induced by KCl exposure was smaller in cardiac myocytes from *miR-1* Tg mice (Fig. [3](#F3){ref-type="fig"}C; n=11 from 8 mice) compared with that in myocytes from WT (*p*\<0.05; n=30 from 6 mice). These results indicated an abnormal handling of intracellular Ca^2+^ in cardiomyocytes from *miR-1* Tg mice.

LNA-anti-*miR-1*restored ion channel abnormalities in Tg mice
-------------------------------------------------------------

The LNA-anti-*miR-1* was found to reverse the decreased *I*~Ca,L~ and *I*~K1\ in\ *miR-1*\ Tg\ mice\ (Fig.\ [4](#F4){ref-type="fig"}A\ &\ [4](#F4){ref-type="fig"}B;\ *p*\<0.05).\ Additionally,\ the\ peak\ \[Ca~^2+^\]~i~ induced by KCl was also decreased in cardiomyocytes from *miR-1* Tg mice compared to that from WT littermates, which was reversed by LNA-anti-*miR-1* (Fig. [4](#F4){ref-type="fig"}C).

Discussion
==========

Here we present the evidence for the role of long-term overexpression of *miR-1* in modulating cardiac electrical activities. The major findings are that long-term *miR-1* overexpression causes AVB of varying degrees in otherwise normal *miR-1* Tg mice. At the subcellular level, long-term *miR-1* overexpression decreases *I*~K1~ and *I*~Ca,L~ densities, and impairs the intracellular calcium handling process as indicated by increased resting \[Ca^2+^\]~i~ and decreased peak \[Ca^2+^\]~i~, which might underlie the AVB-promoting and AVB-inducing effects of *miR-1*. Additionally, our study clearly showed that Cx43 and Kir2.1 expression were downregulated in *miR-1* Tg mice. All these effects were reversed upon knockdown of *miR-1* by LNA-anti-*miR-1*. These findings help us understand the cellular functions of miRNA in particular *miR-1* and the molecular mechanisms underlying the generation of AVB.

Atrioventricular block (AVB) is a common complication of MI, which is relatively frequent and contributes to increased mortality of patients with cardiovascular diseases (CVD) [@B17]-[@B19], and prognostic significance of complete AVB in patients with AMI has been well recognized [@B20]. Upregulation of *miR-1* in myocardial infarction has been reported by several groups. In patients with MI, *miR-1* level was found upregulated by 2.8-fold [@B6] in one study and 3.8-fold in another with the samples of infarcted tissue and remote myocardium from 24 patients with MI [@B21]. A greater degree (\~22 folds) of expression upregulation of *miR-1* was reported in a rat model of MI [@B22]. It is conceivable that *miR-1* overexpression accounts at least partially for the AVB occurring in MI. Unfortunately, because of the technical difficulties and limitations with our mouse model, especially the small size of AV node and the limited quantity of LNA-antimiR for larger animal species, we were unable to investigate this notion in the present study.

AVB can be induced by any disturbances of electrical conduction within the AV node, the bundle of His, and the bundle branches. It is known that L-type Ca^2+^ channels play an essential role in the maintenance of the AV conduction pathways: AV conduction through AV nodal cells is mainly mediated by *I*~Ca,L~, but not by *I*~Na~ as in working myocardial fibers; this is because Na^+^ channels are largely inactivated due to depolarized membrane potential in AV nodal cells that intrinsically have small *I*~K1~[@B13]. Previous study has reported that inhibition of Ca^2+^ channels may be a critical factor contributing to the pathogenesis of congenital heart block [@B14]. Impairment of Ca^2+^ channel function by any factors including repression by *miR-1*is deemed to slowing AV conduction. Moreover, the ability of *miR-1* to diminish *I*~K1~, the primary determinant of resting membrane potential, can further depolarize the membrane of AV nodal cells and the cells in the bundle of His and the bundle branches, and as such manifest the role of *I*~Ca,L~ in governing AV conduction. Here we found a dramatic decrease in *I*~Ca,L~, which may explain the observed AVB, in *miR-1* Tg mice. Though our data were obtained from ventricular myocytes because of the difficulties of isolating single AV nodal cells from mice and even rats, the molecular compositions of L-type Ca^2+^ channels in AV nodal cells have been found to be essentially the same as those in ventricular myocytes [@B23]. It is not unreasonable to speculate that the same mechanism operates in AV nodal cells. Based on our computational analysis, however, none of the cardiac-specific Ca^2+^ channel subunits are predicted to be the targets for *miR-1*. It is possible that *miR-1* acts through indirect pathways to affect Ca^2+^ channel functions. For example, *miR-1* might impair intracellular Ca^2+^ handling process to impose a negative influence to *I*~Ca,L~ [@B24], [@B25]. Indeed, our study demonstrated that overexpression of miR-1 increases resting \[Ca^2+^\]~i~ and decreases peak \[Ca^2+^\]~i~, these changes may well cause reduction of *I*~Ca,L~ through Ca^2+^ induced-Ca^2+^ channel inactivation. Our data showing decrease in *I*~Ca,L~ with *miR-1* overexpression is in contrast to the results reported by other group [@B7] who demonstrated an increase in *I*~Ca,L~ in cultured cardiomyocytes infected with pre-*miR-1*-carrying adenovirus. Though it is not exactly clear what accounts for the discrepancy, one possible explanation is that our study deals with long-term overexpression of *miR-1* in the heart whereas the study by other group focused on transient expression of *miR-1* in cultured myocytes. Long-term overexpression of *miR-1* could well cause electrical and molecular remodeling of cardiac muscles leading to decrease in *I*~Ca,L~.

In heart, the physiological role of *I~K1~* is to accelerate phase III repolarization and to maintain the resting membrane potential (RMP). Lowered Kir2.1 expression prolongs the refractoriness of the atrial and ventricular muscle as well as the His-Purkinje bundle. The decremental conduction property was demonstrated in the His-Purkinje system after Kir2.1 expression decreased in the Tg mice. The T wave amplitude was much reduced, and the repolarization process was slowed. Gap junctions provide cell-to-cell electrical continuity for rapid transmission of cardiac action potential among all cardiac cell types [@B26]. A variable severity of gap junctional disruption alters electrical conduction, increasing risk of arrhythmia [@B27]. Recently, several connexin isoforms have been identified in heart with Cx43 being the primary isoform in ventricular cells. Dysfunction of Cx43 contributes to the perpetuation of re-entry and the degeneration of these arrhythmias [@B28]. Though the existence of Cx43 in AV nodal cells has been a subject of debating, several groups have indeed reported the distribution and function of Cx43 in these cells [@B29]-[@B31]. Under such a context, downregulation of Cx43 by *miR-1* can well cause slowing or even blockade of AV conduction. Alternatively, Cx43 has been shown to exist in the His bundle and the bundle branches, the excitation conduction system critical for AV conduction and suppression of Cx43 in these cells can lead to AVB, too [@B32], [@B33].

In summary, our data demonstrate for the first time that miR-1 induces AVB via the regulation of several important ion channels. miR-1 appears to inhibit Cx43 and Kir2.1 expression, subsequently decreases *I*~K1~ and *I*~Ca,L~ densities, and impair the intracellular calcium handling process. In conclusion, modulation of miR-1 is emerging as a novel approach for the prevention or therapy of AVB related heart diseases.
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![**miR-1 overexpression contributes to the increased susceptibility of the heart to AVB**. (**A**) Verification of the successful transgene. Genomic DNA was prepared from tail tissues of the Tg mice and subjected to PCR verification for the presence of miR-1 transgene. (**B**) Verification of overexpression of endogenous miR-1 in Tg mice. \**p*\<0.01 *vs*. WT; n=6 mice for each bar. (**C**) Expression of connexin 43 (Cx43) protein level was downregulated in miR-1 Tg mice. Top, examples of western blot bands; bottom, quantitation as mean ± s.e.m. (n=6). \*P \<0.05; unpaired Student\'s t-test. (**D**) The representative raw traces of ECG from a miR-1 Tg mouse compared with the WT mouse. (**E**) AVB incidence expressed as percentage of animals in Tg mice. \*\**p*\<0.01 *vs*. WT; n=14 mice for each bar. (F) Representative raw traces of ECG from a miR-1 Tg before and after LNA-miR-1 was injected. (**G**) qPCR analysis showing the miR-1 level after LNA-modified anti-miR-1 injection.](ijbsv09p0455g01){#F1}

![**Verification of ventricular electrical remodeling in miR-1 Tg mice.** (**A**) Whole-cell patch-clamp results for L-type Ca^2+^ current *I*~Ca~ in isolated ventricular cardiomyocytes from mice. Typical *I*~Ca~ recordings (top) and current density (pA/pF)-voltage (mV) relationships of *I*~Ca~(bottom) elicited by 300-ms pulses stepped from -40 to +60 mV in 10 mV increments from the holding potential -40 mV in cells, \**p*\<0.05 *vs* Ctl; n=12 cells for each group. (**B**) Whole-cell patch-clamp results for inward rectifier K^+^ current *I*~K1\ in~isolated ventricular cardiomyocytes from mice (top), average data for current density (pA/pF)-voltage (mV) relationships of *I*~K1~ (bottom) elicited by 100-ms pulses stepped from -120 to 0 mV in 10 mV increments in cells. \**p*\<0.05 *vs* Ctl; n=11 for each group.](ijbsv09p0455g02){#F2}

![**Changes of Intracellular Calcium (\[Ca^2+^\]~i~) in Cardiac Myocytes in miR-1 Tg mice.** (**A**) The images of change of intracellular of Ca^2+^. Different color indicates the different fluorescence intensity. The colorful zoom of yellow indicates the maximum change of Ca^2+^, red and blue indicates the decreased Ca^2+^ in the state of recovery, and green indicates the minimum of change of Ca^2+^compared with the other three colors. (**B**) The resting level of intracellular fluorescent intensity (FI) value (indicator of resting \[Ca^2+^\]~i~ ) was significantly elevated in isolated ventricular myocytes from miR-1 Tg mice compared with WT control. \**p*\<0.05 *vs* Ctl; n=13 cells from 4 mice for control and n=20 cells from 4 mice for Tg group. (**C**) Changes of \[Ca^2\ +^\]~i~ elevation induced by 60 mmol·L^-1^ KCl in isolated mouse ventricular myocytes. Qualitative changes in \[Ca^2+^\]~i~ were inferred from the ratio of FI/FI~0~. miR-1 overexpression reduced the \[Ca^2\ +^\]~i~responded to KCl.](ijbsv09p0455g03){#F3}

![**Effects of miR-1 knockdown on AVB and the associated electrical remodeling**. (**A**) Reduced *I~Ca~*~,L~ density in cardiomyocytes from miR-1 Tg mice was recovered by injection of LNA-modified anti-miR-1. Upper panel: *I~Ca,~*~L~ trace recorded at the test potential of 10 mV. Lower panel: I-V relationship of *I~Ca,~*~L.~ (**B**) Reduced *I~K1~* density in cardiac myocytes of miR-1 Tg mice was also recovered by injection of LNA-modified anti-miR-1. Upper panel: *I~K1~* trace recorded at the test potential of -120 mV. Lower panel: I-V relationship of *I~K1~*~.~ (**C**) Effects of LNA\--modified anti-miR-1on the changes of \[Ca^2+^\]~i~ of cardiac myocytes in miR-1 Tg mice. \**p*\<0.05 *vs* Ctl; n=10 cells from 4 mice for control and Tg group. \#*p*\<0.05 *vs* Tg group; n=10 cells from 4 mice.](ijbsv09p0455g04){#F4}

[^1]: \* The first two authors made equal contribution to this work.

[^2]: Conflict of Interests: The authors have declared that no conflict of interest exists.
